Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to assess the pharmacokinetics of Venofer (Iron Sucrose Injection) in NDD-CKD pediatric patients.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
American Regent, Inc.
NCT03520647 · Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), and more
NCT05012111 · Severe Aplastic Anemia, Telomere Biology Disorders, and more
NCT07281781 · Myelofibrosis, Myelofibrosis; Anemia
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT07039422 · Primary Immune Thrombocytopenia, Warm Autoimmune Hemolytic Anemia
Luitpold Pharmaceuticals
Norristown, Pennsylvania
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions